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Background: Oxidative stress is involved in several pathologic conditions such as metabolic or cardio-
vascular disease, and in aging. Oxidative damage of biomolecules increases with age. Melatonin is the
main neurohormone of the pineal gland and speciﬁc antioxidants may act against age-related oxidative
damage.
Objective: This study investigated the effects of administration of melatonin on aging-related parameters
such as total oxidant status (TOS), hydrogen peroxide (H2O2) and lipid hydroperoxide (LOOH) levels and
total antioxidant capacity (TAC) in the heart and liver in a rat model of aging.
Methods: Young (3-month-old) and aged (24-month-old) male Wistar rats were divided into control and
melatonin-treated groups. Melatonin was given for 21 days (10 mg/kg/day). At the end of the treatment
period, TOS, TAC, H2O2, and LOOH levels were measured.
Results: H2O2 in the liver, but not in the heart, was found to be increased in aged rats. Melatonin
treatment diminished H2O2 in the heart of both group of rats compared with those of untreated control
rats. Melatonin treatment also led to a decrease in H2O2 in the liver of aged rats. LOOH were found to be
increased in both tissues of aged rats whereas melatonin treatment decreased LOOH levels in heart and
liver tissues of aged rats. In the young rats melatonin also inhibited LOOH in liver. TAC in heart and liver
was not found to be statistically different between young and aged rats. In young rats, melatonin
treatment resulted in an increase in TAC that was associated with increased H2O2. In the liver and heart of
the rats, TOS was increased with age and was ameliorated by melatonin treatment.
Conclusion: Our results demonstrate that there is no dramatic overall decline in the antioxidant system
with age. However, total oxidant status increased with age. Melatonin has a restorative effect on
oxidative status.
Copyright  2012, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Because aging is a natural process of life, studies on aging have
great importance. Changes in the physiologic mechanisms during
aging affect the welfare of elderly people. Gradual decay of physi-
ologic functions, which is a natural consequence of aging, is asso-
ciated with several complexmechanisms. One of the most accepted
theories is the free radical theory of aging. This theory underlines
the key role of oxidative stress in age-related degradation of
physiologic functions1,2. Oxidative stress is the usual phrase used tore.
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iwan Society of Geriatric Emergenidentify the association of the toxic free radicals with damage to
cells and tissues3,4. Oxidative stress can be described as a disparity
between reactive oxygen species (ROS) and antioxidant systems in
favor of ROS. Oxidative stress has been reported to affect most of
the vital organs during aging1,2,4,5. According to the free radical
theory of aging, accumulated damage caused by ROS and other
reactive molecules may alter the structure and function of the cells
and tissues6,7.
The liver and heart are more prominent organs affected by
aging. The liver is more susceptible to oxidative damage because it
is mainly involved in metabolism and detoxifying processes in the
body. Increased ROS and oxidative stress in liver have been asso-
ciated with aging in rats1,8,9. Like the liver, the heart is a vital organ
with high metabolic demand that is rich in mitochondria; it is
especially vulnerable tomitochondrial oxidative damage. Increased
oxidative damage indicators in aged hearts were documented10.cy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Liver and heart hydrogen peroxide levels (H2O2). Results are expressed as the
mean  standard error of the mean. Liver: #YC-YM p ¼ 0.038, *YC-AC p ¼ 0.005, ##AC-
AM p ¼ 0.005. Heart: þYC-YM p ¼ 0.033, zAC-AM p ¼ 0.006. AC ¼ aged control;
AM ¼ aged melatonin; YC ¼ young control; YM ¼ young melatonin.
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radical scavenger that protects cells from damage induced by
a variety of oxidants including hydroxyl radical and lipid perox-
idation products11,12.Because melatonin is able to cross through
biologic membranes because of its lipophilic nature, it exerts its
effects in different compartments of the cells, from the membrane
through the subcellular organelles. The production of melatonin
decreases markedly with advancing age, thereby leaving the
organism deprived of one of its seemingly most potent anti-
oxidative defense mechanism3.
A decrease in pineal functions of aged animals led to suggestions
regarding the possible role of melatonin in aging. The mechanisms
for oxidative cellular damage during aging are poorly understood.
In the current study we aimed to investigate the possible protective
effects of melatonin on the liver and heart in young and aged rats,
by affecting oxidative/antioxidative capacity and dealing with the
possible association between antioxidants, oxidants, and the aging
process.
2. Methods
A total of 24 young and aged male Wistar rats were used in the
study. Twelve young rats (age 3 months) were divided into two
groups as control (6 rats) and melatonin-treated animals (6 rats).
Similarly, 12 aged rats (aged 24 months) were divided into two
groups (control with 6 rats and melatonin-treated with 6 rats). All
the animals were kept under laboratory conditions with equal
periods of light and dark (08:00e20:00 hours). Melatonin was
given subcutaneously at a dose of 10 mg/kg/day dissolved in 1%
ethanol in phosphate-buffered saline (PBS) at 18:00 hours for 21
days. Control rats received equal amounts of 1% ethanol in PBS for
the same period. At the end of the 3rd week, all the animals were
sacriﬁced by decapitation and heart and liver tissues were removed
and frozen in liquid nitrogen and kept at 86 C.
Total antioxidant capacity (TAC) was measured colorimetrically
according to the assay kit protocol (Dr Franz Tatzber, KEG, Austria).
The determination of peroxides is based on the reaction of perox-
ides with peroxidase followed by a color reaction of the chromo-
genic substrate tetramethylbenzidine. Its blue color changes to
yellow after addition of the stop solution and can be measured
photometrically at 450 nm. Quantiﬁcation is achieved by serial
dilution of a standard Trolox solution (Dr Franz Tatzber, KEG,
Bisamberg, Austria). Total oxidative capacity (TOC) was determined
with an enzymatic test kit for the measurement of peroxide in
tissue extracts (Dr Franz Tatzber, KEG, Bisamberg, Austria). Quan-
tiﬁcation is achieved by serial dilutions of a standard peroxide
solution. Lipid hydroperoxide (LOOH) levels in tissue homogenates
were measured with a commercial assay kit (Cayman Chemicals,
Ann Arbor, MI, USA). According to the assay protocol, tissue
homogenates were extracted in chloroform supplemented with
Extract R saturated methanol. A total of 500 mL chloroform-
extracted homogenates were mixed with 50 mL ferrous sulfate
and 50 mL methanolic ammonium thiocyanate solutions and incu-
bated 5 minutes in room temperature. After incubation absorbance
values of samples were measured at 500 nm with microplate
reader. There were 0e5 nmol hydroperoxide standards used in this
assay for calculation. Tissue hydrogen peroxide (H2O2) levels were
measured using a colorimetric assay kit (Oxis International, Port-
land, OR, USA). Assay is based on the oxidation of ferrous ions to
ferric ions by hydrogen peroxide under acidic condition.
2.1. Statistical analysis
Statistical signiﬁcancewas tested by two-wayanalysis of variance
followed by the Tukey test. A level of p < 0.05 was consideredstatistically signiﬁcant. The results are expressed asmean standard
error of the mean (SEM) for six animals in each group.
3. Results
3.1. H2O2 levels in the liver and heart
H2O2 levels in the liver were increased with age (p ¼ 0.005).
Melatonin treatment decreased H2O2 levels of the liver in the aged
group (p ¼ 0.005), but melatonin treatment increased liver H2O2
levels in the young rats compared with those of the control group
(p¼ 0.038) (Fig.1). H2O2 levels in the heart did not changewith age.
However, melatonin decreased heart H2O2 levels in both young and
aged groups compared with those of the control groups (p ¼ 0.033,
p ¼ 0.006, respectively) (Fig. 1).
3.2. LOOH levels in the liver and heart
Liver LOOH levels were increased with age (p ¼ 0.003) and
melatonin treatment decreased LOOH levels in the young and aged
rats compared with those of the control groups (p ¼ 0.002,
p¼ 0.004) (Fig. 2). In addition, LOOH levels were increased with age
in the heart (p < 0.001). Melatonin treatment decreased LOOH
levels in the aged group (p < 0.001) and LOOH levels in the
melatonin-treated group of the young rats did not change
compared with those of the control group (Fig. 2).
3.3. TAC of the liver and heart
TAC did not change with age in the liver and heart (Fig. 3).
However, melatonin increased TAC in the liver of young rats
compared with those of the control group (p ¼ 0.001).
3.4. Total oxidant status of the liver and heart
Total oxidant status (TOS) was increased with age in the liver
(p¼ 0.005). Melatonin treatment decreased TOS in the liver of both
young and aged rats compared with those of the control groups
(p ¼ 0.048, p < 0.001, respectively) (Fig. 4). TOS in the heart
increased with age (p < 0.0038). Melatonin treatment decreased
TOS in the heart of young and aged rats compared with those of the
control groups (p < 0.001) (Fig. 4).
Fig. 2. Liver and heart lipid hydroperoxide levels (LOOH). Results are expressed as the
mean  standard error of the mean. Liver: #YC-YM p ¼ 0.002, *YC-AC p ¼ 0.003, ##AC-
AM p ¼ 0.004. Heart: þ YC-AC p < 0.001, zAC-AM p < 0.001. AC ¼ aged control;
AM ¼ aged melatonin; YC ¼ young control; YM ¼ young melatonin.
Fig. 4. Liver and heart total oxidant status. Results are expressed as the
mean  standard error of the mean. Liver: #YC-YM p ¼ 0.048, *YC-AC p ¼ 0.005, ##AC-
AM p < 0.001. Heart: þYC-YM p < 0.001, zYC-AC p ¼ 0.0038, **AC-AM p < 0.001.
AC ¼ aged control; AM ¼ aged melatonin; YC ¼ young control; YM ¼ young melatonin.
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The possibility that oxidative stress and aging are mainly due to
a decline in antioxidant defenses is still not clear. We will discuss
some of our ﬁndings in the liver and heart of the young and aged
rats and we will also discuss the effects of melatonin on these
parameters.
Free radicals increase with age, alter physiologic function,
increase disease states, and accelerate pathophysiologic condi-
tions4,5,13,14. The overproduction of radicals can induce oxidative
stress and cell death4,15. Aging is characterized by increased
production of radicals in several tissues5,13,15,16. H2O2 may be one of
the causal factors underlying the agingprocess.Melatonin is ahighly
efﬁcient free radical scavenger and antioxidant both in vitro and
in vivo17. H2O2 and melatonin are present in all subcellular
compartments; thus, one important function of melatonin may be
complementary in function to catalase and glutathione peroxidase
in keeping intracellularH2O2 concentrations at steady-state levels18.
In our study, H2O2 levels in the liver increased with age. H2O2
production was decreased by melatonin treatment in the aged rats.Fig. 3. Liver and heart total antioxidant capacity. Results are expressed as a mean-
 standard error of the mean. Liver: #YC-YM p ¼ 0.001. AC ¼ aged control; AM ¼ aged
melatonin; YC ¼ young control; YM ¼ young melatonin.However, melatonin treatment in the young rats increased H2O2
levels. Whereas the liver in general has a well-developed anti-
oxidative defense system to protect against free radicals, treatment
with melatonin in the young rats increased H2O2 levels. High levels
of melatonin were found in the bile of a variety of species. The
melatonin in the bile is likely to have been excreted by the liver.
Therefore, the liver may normally contain higher amounts of this
antioxidant than do most other organs. This may have helped to
protect the liver from oxidative damage19. The activity of super-
oxide dismutase (SOD), which dismutates O2e to H2O2, is increased
by melatonin20e25. We observed an increase in SOD levels
(p ¼ 0.063) in the liver of melatonin-treated young rats compared
with that in control rats (unpublished data). This increase was not
statistically signiﬁcant, but was close to statistically signiﬁcant.
Because SOD stimulates H2O2 formation, an increase in SOD activity
might be the reason for elevated H2O2 levels in melatonin-treated
young rats. However, melatonin treatment decreased heart H2O2
levels in both young and aged groups compared with those of
control groups. However, H2O2 levels in the heart did not increase
with age. Many studies have reported an increase in cardiac mito-
chondrial oxidant production with age26e29, but others have re-
ported no changes in H2O2 production with age26,30e32.
LOOHs are primary lipid peroxidation products formed when
omega-6 polyunsaturated fatty acids, such as linoleic acid, react
with free radical species. The reactivity of LOOHs cause protein
damage within tissues33. LOOH levels were increased in the liver
and heart with age. Melatonin treatment decreased LOOH levels in
the liver of young rats and aged rats. Furthermore, melatonin
treatment decreased heart LOOH levels in the aged rats. However,
LOOH levels did not change in the heart of the young control and
young melatonin-treated groups. The ﬁnding that LOOH formation
is likely to have a negative effect on the heart is supported by
studies demonstrating that the exogenous application of LOOH can
induce cardiac dysfunction33,34. Free radical production leads to
generation of LOOH, which covalently attaches to proteins. The
formation of LOOH-modiﬁed proteins in ischemic cardiac tissue
was shown33. LOOH modiﬁcation of proteins can lead to enzymatic
and cellular dysfunction33. Previous studies have reported that it
is possible that some variations in thiobarbituric acid reactive
substances (TBARS) and protein carbonyls can arise from a combi-
nation of factors such as tissue-speciﬁc differences in rates of
oxidant generation, antioxidant defenses, repair mechanisms, and
chemical composition35e37. In our study, LOOH levels were reduced
S¸. Güney et al.48by melatonin, which in the heart and liver was increased with
aging. Our results showed that melatonin has a protective effect on
the heart and liver tissues against the harmful effects of LOOH.
It is indicated that melatonin is a key regulator of aging and
senescence38,39 and the pineal gland may act as an endogenous
clock governing aging39. There are many reports that melatonin
levels decline with aging in humans39e42 and in animals43,44. The
age-related increases in the level of oxidative stress may be due to
enhancement of the rate of ROS generation16. Age-associated
decline in antioxidant defenses is neither widespread nor very
impressive in magnitude16. It is hypothesized that variations in the
rates of aging in different species, which are otherwise closely
related phylogenetically, may be in part due to differences in rates
of O2e and H2O2 production16. In our study, TAC in the liver and
heart tissues did not change with age. However, melatonin only
increased TAC in the liver of the young rats compared with those of
the control group. This ﬁnding in the young liver might be
a response against increased H2O2 by melatonin.
We observed differential effects of exogenous melatonin on the
body weight changes in the current study. Exogenous melatonin
signiﬁcantly decreased the body weight increments in the young
group (body weight increase in the young control group: 56.5 6.3,
young melatonin group: 30.5  3.7; p ¼ 0.009) during the experi-
ment. In contrast, although not signiﬁcant, melatonin decreased the
bodyweight decrement in the aged group (body weight decrease in
the aged control group: 51.0  11.1, aged melatonin group:
34.2.0  6.0; p ¼ 0.240). No signiﬁcant correlation was found
between thebodyweight changes andhydrogenperoxide levels.We
found that the liverH2O2 levels of young rats treatedwithmelatonin
were signiﬁcantly higher than that of the aged group of melatonin.
This ﬁnding may be partly explained by the already increased
endogenous melatonin levels in the young which were reported
previously1,44. Exogenous melatonin might have a profound effect
on the oxidative stress levels of the aged group, which has depleted
levels of melatoninwith increasing age45. TOS increasedwith age in
the liver and heart. Melatonin treatment decreased TOS in the liver
and heart of both young and aged rats. Sohal and Orr16 suggested
that the rates of oxidant generation are a better correlate of the rates
of aging than are the levels of antioxidant defenses. Our ﬁndings are
consistent with the ﬁndings of these researchers, and our results
suggest that the effects of aging on TOC in the tissues may be more
than for TAC. In humans, the TAC of serum is related to melatonin
levels. Thus, the reduction in melatonin with age may be a factor in
increased oxidative damage in the elderly45.
As a result, oxygen species may be one of the causal factors
underlying the aging process. To our knowledge this is the ﬁrst time
that a relationship between melatonin and the levels of H2O2,
LOOH, TOS, and TAC in heart and liver tissues of the young and aged
rats has been observed. Our results demonstrate that there is no
dramatic overall decline with age of the TAC. However, TOS, H2O2,
and LOOH levels increased with age. Melatonin has a restorative
effect on oxidative status in aged rats, and thus may have potential
importance to regulate cellular redox homeostasis during the aging
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